MONOHYDRATEMANUAL
A reader’s handbook
for creatine powder.

The index

ALL CHAPTERS.

Product files, ingredient explanations and a closer look at the evidence.

Chapter kind

21 chapters shown

01
Review · Sponsored first placement

CoreAge Rx creatine review: the Strong Suit label, price and open questions

The 5 g creatine amount within a 5.6 g scoop, current $39 single-month offer and larger one-time bundles, with evidence limits.

02
Review

Naked Nutrition creatine review: a large tub and a closer look at certification

The unflavored 2.2LB container, contents certification and changing autoship discount.

03
Review

Thorne creatine review: following the sport-certification record

The 90-serving powder, its public NSF entry and why a specific lot still matters.

04
Review

Transparent Labs Creatine HMB review: what the blend adds

Four declared ingredients, recurring purchase terms and the limits of flavored-batch reports.

05
Comparison

Best creatine monohydrate powders: compare the facts before the pitch

CoreAge leads as the disclosed sponsor; compare formula, testing, quantity and buying terms.

06
Guide

Creatine monohydrate explained: what is actually in the powder?

A practical introduction to the ingredient, its evidence and the language on the tub.

07
Guide

Micronized creatine vs monohydrate: two labels, one important distinction

Particle size and chemical form describe different things; a mixing claim is not a clinical advantage.

08
Guide

How to check creatine testing: from a logo to a useful record

Separate contents testing, sport screening and sample reports, then match the product and lot.

09
Guide

Creatine loading and serving sizes: read the numbers without making a dosing plan

A scoop, an ingredient amount and a research protocol are different numbers with different jobs.

10
Guide

Creatine and kidney blood tests: why context matters more than one number

What a 2025 review found, where its limits remain and what to tell your clinician.

11
Review

ALLMAX creatine review: one ingredient, several package records

The selected 400g price, mismatched serving counts, label warnings and testing limits.

12
Review

Promix creatine review: the large package and the refund fine print

A 180-serving label, recurring purchase terms and the limits of a broad guarantee.

13
Guide

Creatine HCl vs monohydrate: what direct comparisons can establish

Solubility, actual comparison groups and why small servings do not establish equivalent outcomes.

14
Guide

Creatine storage and mixed drinks: three situations, different questions

Keep package dates, dry-powder instructions and a prepared drink’s requirements separate.

15
Guide

Creatine and type 2 diabetes: reading a small trial without replacing care

A 25-person exercise study, HbA1c interpretation and the boundaries of treatment claims.

16
Guide

Creatine without resistance training: what the study design changes

Newer and older trials, participant-selected exercise and the difference between lean tissue and a promise.

17
Review

NutraBio creatine review: the 500g label and the policy mismatch

The selected 100-serving powder, catalog-based price, lot-lookup limits, wrapper warnings, and conflicting official return terms.

18
Guide

Creatine ethyl ester vs monohydrate: read the direct trial by outcome

A seven-week comparison separates blood markers, muscle stores and training results without establishing a personal regimen.

19
Guide

Creatine vs creatine kinase: understand which blood test you are reading

Creatine, creatine kinase and creatinine answer different questions; clinical context, symptoms and the actual product list matter.

20
Guide

Creatine and Parkinson’s disease: follow the large trial to its result

What the 1,741-participant study tested, why it stopped for futility, and why an early biological rationale is not a disease-slowing result.

21
Guide

Creatine and COPD rehabilitation: muscle findings are not the whole result

An earlier mixed trial and a larger study without added rehabilitation benefit, with population, completion counts and clinical limits kept visible.